8-KThe WireRoutine
Reg FD Disclosure
Filed Mar 10, 2026 · 3mo ago · Accession 0001104659-26-025420
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Aclaris Therapeutics, Inc.
- Ticker
- ACRS
- CIK
- 1557746
- Form type
- 8-K
- Filing date
- Mar 10, 2026
- Report date
- Mar 9, 2026
- Document
- acrs-20260309x8k.htm
- Size
- 141 KB